For three months straight, all any company, even those that have been dormant for years, needed to do was mention marijuana and instant gains appear – almost all of which have been over 1,000%. Such is unlikely to be the case when it comes to the penny stock of MediJane Holdings Inc. (MJMD) which just signed a licensing deal with Phoenix Bio Pharmaceuticals Corp. to exploit their medical cannabinoid products and delivery systems. While exploiting a company whose web presence didn’t exist until last week might sound like a good reason to buy MJMD stock, the legal team behind the shell and the former CEO will give you more than enough reasons not to.
Our Next Pick Is Coming Soon!
Click HERE To Make Sure You Don’t Miss Any Of Our Hot Penny Stock Alerts!
MJMD Stock Quote
Market Cap: 90.09M
Last: 1.43 ▼ -0.04 (-2.72%)
Dollar Volume: $1,122,160
Issued and Outstanding: 104,000,000
14-Day Rel Strength: N/A
1st Resistance Point: 1.5567
1st Support Level: 1.2767
Looking for the Best Penny Stocks to Buy?
Click HERE To Receive FREE Penny Stock Alerts
MediJane Holdings hit everyone promo player’s radar last week when shares of the newly formed medical marijuana focused company began to trade. Looking like the next big thing to hit the cannabis sector with their new licensing deal with Phoenix Bio Pharmaceuticals Corporation, a company which has no internet presence of any kind whatsoever except the PR and 8K filing, the warning signs of MJMD stock being one of the riskiest plays out there are overflowing with bad connections.
MJMD is undoubtedly going to be the highlight of an upcoming stock promotion. Besides the recent 10-for-1 stock split to ready the ticker and entry into the one sector that needs no promoting, the medical marijuana sector, connections like Carrillo, Huettel & Zouvas, LLP having been the attorney for Mokita Inc. (MKIT) and Irma N. Colón-Alonso having been the former sole director are enough to make MJMD stock a prime candidate to be suspended by the SEC.
Carrillo, Huettel & Zouvas, LLP was the law firm that incubated nearly all of the 30+ shells that Awesome Penny Stocks promoted when they were in the game, raising over $3 billion in the course of three years. Those familiar with their history know that the law firm and the group are no longer in existence due to a real life version of “Catch Me If You Can,” however not every one who plays the pennies knows this.
Another bad sign for MJMD which increases their odds of being a losing trade was that when Mokita Inc. was preparing to strike it rich in the oil business after buying a working interest from Buckeye Exploration Company, their CEO, Irma N. Colon-Alonso, was teaching Zumba classes in Miami. Irma was the CEO until May of last year of Dephasium Corp. (DPHS), a suspect once to be a pick of Awesome Penny Stocks, which turned out to be one of the worst front-loaded penny stocks of last year dropping from 0.61 to 0.09 before you could spell out D-E-P-H-A-S-I-U-M.
Continuing on with the warning signs, Mokita brought on attorney Eric P. Littman back in 2011 to be a member of the Company’s Board of Directors. Joining Colon-Alonso as shareholders of the Company, 1,500,000 pre-split shares, until his resignation on February 14, 2012, the SEC’s unconcern over Littman’s single count of alleged engagement in the sale of unregistered securities from 2000 should be another warning for those thinking to get involved with MJMD.
Lastly, a major warning sign comes from the shell of a company, MediJane Holdings, now having the right to exploit medicinal marijuana products through the licensing deal they struck with Phoenix Bio Pharmaceuticals Corporation. With no documented existence of any kind except for the licensing deal and PR issued by MediJane, the signature on the deal is that of Spike Humer. Now, one must think the name is as unique as any when trying to find some reality behind Phoenix Bio Pharmaceuticals, but even with what we could find for a very famous Spike Humer, no mention of any kind exists about any company created that has any medical cannabinoid products and delivery systems for the treatment and management of illnesses.
Warning after warning after warning is there in plain view indicating that MJMD stock has all of the odds stacked against it to be a winner. Does this mean that MJMD stock won’t be a $5 stock in a couple of weeks or a $0.50 stock in a couple of days? The best bet is to sit on the sidelines and watch rather than have money on the rigged game knowing that you’re unlikely to cash in a winning ticket.
About MJMD Stock
MediJane Holdings Inc. is a start up company that, through a recent licensing agreement with Phoenix Bio Pharm, intends to exploit medicinal cannabis products such as transdermal patches, orally administered extracts, concentrated extracts for vaporisers and inhalers, sublingual and buccal dispensing products and extraction technology, suppository delivery systems, salves, creams, gels, lotions, and liquid extracts, and any products or active ingredients sources.
Last 5 Trading Sessions:
MJMD is simply just tainted – head to toe, left to right. The chances of APS’s affiliate, the Victory Mark group, issuing penny stock alerts of MJMD stock are unlikely, but you can never count them out considering the direction connection with their money tree – Carrillo, Huettel & Zouvas, LLP. PTOG and AVNE were already halted for not playing the game correctly. With a phony looking licensing deal, chances are this one is going to see the same fate.
[gravityform id=”6″ name=”Post” title=”false”]Share